Skip to main content

Table 2 The status of asthma control drug usage among children in the different age groups, regions and city levels

From: Characteristics of medicine use for children with asthma in China: a nationwide population-based study

 

Age groups

 

Regions

 

City levels

 

Children younger than 3 years old

Preschool children

School-age children

P

East China

Central China

West China

P

1st Tier

2nd Tier

3rd Tier

4th and 5th Tier

P

(N = 439)

(N = 967)

(N = 1062)

(N = 1900)

(N = 223)

(N = 345)

(N = 601)

(N = 1268)

(N = 195)

(N = 314)

ICS

346 (78.82%)

687 (71.04%)

512 (48.21%)

 < .0001

1356(71.37%)

106(47.53%)

83(24.06%)

 < .0001

411(68.39%)

854(67.35%)

132(67.69%)

148(47.13%)

 < .0001

LABA

181 (41.23%)

354 (36.61%)

258 (24.29%)

 < .0001

731(38.47%)

25(11.21%)

37(10.72%)

 < .0001

301(50.08%)

405(31.94%)

51(26.15%)

36(11.46%)

 < .0001

ICS + LABAa

160 (36.45%)

300 (31.02%)

198 (18.64%)

 < .0001

613(32.26%)

19(53%)

26(7.54%)

 < .0001

239(39.77%)

350(27.60%)

43(22.05%)

26(8.28%)

 < .0001

ICS/LABAb

0

195 (20.17%)

158 (14.88%)

 < .0001

180(9.47%)

3(1.35%)

5(1.45%)

 < .0001

75(12.48%)

66(5.21%)

36(18.46%)

11(3.50%)

 < .0001

LTRA

195(44.42%)

558 (57.70%)

270 (25.42%)

 < .0001

1141(60.05%)

37(16.59%)

47(13.62%)

 < .0001

359(59.73%)

693(54.65%)

101(51.79%)

72(22.93%)

 < .0001

  1. aICS + LABA means both of ICS and LABA are used together
  2. bLABA/ICS is a compound preparation